Makoto Hosono,
Jean-François Chatal
Resistance to Ibritumomab in Lymphoma
Gebonden Engels 2018 9783319782379
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
Specificaties
ISBN13:9783319782379
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer International Publishing
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Inhoudsopgave
<div>Clinical Use and Efficacy of Ibritumomab in B-cell Lymphoma.- Biology and Pathology of B-cell lymphoma.- Resistance to Y-90 Ibritumomab Tiuxetan Therapy.- Features of Ibritumomab as Radionuclide Therapy.- Radiological Evaluation of Response and Resistance of Ibritumomab.- Characteristics of Ibritumomab as Radionuclide Therapy Agent.- Resistance and Heterogeneity of Intratumoral Antibody Distribution.- Radiation Dosimetry in Ibritumomab Therapy.- Combining RAIT and immune-based therapies to overcome resistance in cancer?.- Prospects for enhancing efficacy of radioimmunotherapy.- Index.</div>
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan